FACCHINETTI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 123
NA - Nord America 28
AS - Asia 20
AF - Africa 1
Totale 172
Nazione #
IT - Italia 54
IE - Irlanda 32
US - Stati Uniti d'America 26
FR - Francia 14
DE - Germania 9
CN - Cina 6
JP - Giappone 6
SG - Singapore 4
FI - Finlandia 3
CA - Canada 2
CH - Svizzera 2
GB - Regno Unito 2
NL - Olanda 2
RO - Romania 2
BE - Belgio 1
EG - Egitto 1
ES - Italia 1
IN - India 1
IR - Iran 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
Totale 172
Città #
Dublin 32
Casina 11
Bremen 9
Ashburn 6
Milan 6
Shanghai 6
Rome 4
Boardman 3
Correggio 3
Helsinki 3
Missaglia 3
Pisa 3
Vicopisano 3
Bacau 2
Bologna 2
Elkins Park 2
London 2
Padova 2
Taranto 2
Toronto 2
Amsterdam 1
Arlington 1
Baltimore 1
Bangkok 1
Cairo 1
Chicago 1
Council Bluffs 1
Enschede 1
Fayetteville 1
Gaithersburg 1
Iseo 1
Istanbul 1
Los Angeles 1
Marsciano 1
Mashhad 1
Mercato San Severino 1
Misano Adriatico 1
Montichiari 1
Neviano degli Arduini 1
New Delhi 1
Orlando 1
Roncoferraro 1
Salerno 1
San Diego 1
Schoten 1
Suitland 1
Tacoma 1
Turin 1
Urbino 1
Vicenza 1
Vigo 1
Totale 137
Nome #
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination, file e177fbc7-a6a3-50b0-e053-d805fe0adaee 36
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors, file e177fbc7-9e55-50b0-e053-d805fe0adaee 29
Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: A systematic review and meta-analysis, file e177fbc7-a766-50b0-e053-d805fe0adaee 25
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors, file e177fbc7-a7af-50b0-e053-d805fe0adaee 15
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: A systematic review and meta-analysis, file e177fbc7-a9c4-50b0-e053-d805fe0adaee 14
Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?, file e177fbc8-0437-50b0-e053-d805fe0adaee 13
Cystic brain metastases and RET fusion in lung cancer, file e177fbc7-a54d-50b0-e053-d805fe0adaee 12
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib, file e177fbc7-a358-50b0-e053-d805fe0adaee 11
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy, file e177fbc7-a416-50b0-e053-d805fe0adaee 9
Exploring the role of respiratory microbiome in lung cancer: A systematic review, file e177fbc7-aae6-50b0-e053-d805fe0adaee 6
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib, file e177fbc7-a7bb-50b0-e053-d805fe0adaee 1
Osimertinib in CNS-progressive EGFR-mutant lung cancer: do we need to detect T790M?, file e177fbc7-a7bd-50b0-e053-d805fe0adaee 1
Totale 172
Categoria #
all - tutte 482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 11 0 2 10 0 3
2022/2023114 6 5 0 11 10 0 10 6 46 5 13 2
2023/202432 0 2 1 0 3 2 11 6 1 6 0 0
Totale 172